In today’s recent session, 1.6 million shares of the Moleculin Biotech Inc (NASDAQ:MBRX) have been traded, and its beta is 1.96. Most recently the company’s share price was $0.59, and it changed around -$0.11 or -16.52% from the last close, which brings the market valuation of the company to $1.99M. MBRX at last check was trading at a discount to its 52-week high of $10.35, offering almost -1654.24% off that amount. The share price’s 52-week low was $0.66, which indicates that the recent value has fallen by an impressive -11.86% since then. We note from Moleculin Biotech Inc’s average daily trading volume that its 10-day average is 0.26 million shares, with the 3-month average coming to 94.36K.

Moleculin Biotech Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended MBRX as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Moleculin Biotech Inc is expected to report earnings per share of 0 for the current quarter.

Moleculin Biotech Inc (NASDAQ:MBRX) trade information

Instantly MBRX has been showing red trend so far today with a performance of -16.52% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.2899 on recent trading dayincreased the stock’s daily price by 54.26%. The company’s shares are currently down -65.43% year-to-date, but still down -52.22% over the last five days. On the other hand, Moleculin Biotech Inc (NASDAQ:MBRX) is -64.16% down in the 30-day period. We can see from the shorts that 0.17 million shares have been sold at a short interest cover period of 2.62 day(s).

Moleculin Biotech Inc (MBRX) estimates and forecasts

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 18.25%. Moleculin Biotech Inc earnings are expected to increase by 49.80% in 2025, but the outlook is positive 36.38% per year for the next five years.

Moleculin Biotech Inc (NASDAQ:MBRX)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 3.34% of Moleculin Biotech Inc shares, and 15.35% of them are in the hands of institutional investors. The stock currently has a share float of 15.88%.

Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 42.47 shares worth $24295.0, making up 1.33% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 30.31 shares worth around $17342.0, which represents about 0.95% of the total shares outstanding.